��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Population Pharmacokinetics of Eslicarbazepine Acetate in Patients with Partial-Onset Seizures

Topic Epilepsy

Presentation(s) (-)

Poster/Presentation
Number 044

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Mark Versavel, MD, PhD (VZenium LLC)	An immediate family member of Dr. Versavel has received personal compensation for serving as an employee of Cerevel. Dr. Versavel has received personal compensation for serving as an employee of Eliem. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bial. Dr. Versavel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Grunenthal. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alkermes. Dr. Versavel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Versavel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aptinyx. Dr. Versavel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alzheon. Dr. Versavel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Finch. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Maplight. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Praxix. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Confo.
Jahnavi Kharidia, PhD, RPh, RAC (Sunovion Pharmaceuticals Inc.)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Gary Maier, PhD (Sunovion Pharmaceuticals Inc.)	No disclosure on file
Salvador Cruz-Flores, MD, FAAN (Paul L. Foster School of Medicine Texas Tech University Health Sciences Center)	The institution of Dr. Cruz-Flores has received research support from University of Texas System.